Latest revenue growth
Halozyme Therapeutics Revenue growth
Direct answer
Halozyme Therapeutics's revenue growth is 47.7%.
The verified market snapshot reports 47.7%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 26, 2026.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue growth
- 47.7%
Explore related company data
View Halozyme Therapeutics's market capitalizationView Halozyme Therapeutics's p/e ratioView Halozyme Therapeutics's price-to-book ratioView Halozyme Therapeutics's return on equityView Halozyme Therapeutics's dividend yieldView Halozyme Therapeutics's 52-week price rangeView Halozyme Therapeutics's profit marginView Halozyme Therapeutics's debt-to-equity ratioView all Halozyme Therapeutics key metricsReturn to Halozyme Therapeutics profile